Paul E Firuta Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Paul E Firuta.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul E Firuta. Paul E Firuta is a President, US Comm Operations in NPS PHARMACEUTICALS INC ($NPSP) and a Chief Operating Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and a EVP, Chief Commercial Officer in ACHILLION PHARMACEUTICALS INC ($ACHN) and a Chief Commercial Officer in uniQure N.V. ($QURE).
Address: 550 HILL DRIVE BEDMINSTER 07921 NJ
Companies in which Paul E Firuta is an Insider
ACHILLION PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul E Firuta: EVP, Chief Commercial Officer, Chief Operating Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 29 2020
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NPS PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Paul E Firuta: President, US Comm Operations
Holdings: 0 shares
Latest Transaction: Feb 24 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
uniQure N.V.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul E Firuta: Chief Commercial Officer
Holdings: 93,817 shares
Current Value: $597,614
Latest Transaction: Jan 30 2018
$QURE Market Capitalization: $165.39M
$QURE Previous Close: $6.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul E Firuta
Sentiment: All, ACHN, NPSP, QURE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | EVP, Chief Commerci ... | Option Exercise | D | 2.18 | 200,000 | 436,000 | 0 | |
| Jan 29 2020 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | EVP, Chief Commerci ... | Option Exercise | D | 3.32 | 400,000 | 1,328,000 | 0 | |
| Jan 25 2019 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | Chief Operating Off ... | Option Exercise | A | 2.18 | 200,000 | 436,000 | 200,000 | |
| Sep 12 2018 | ACHN | ACHILLION PHARMACE ... | Firuta Paul E | Chief Operating Off ... | Option Exercise | A | 3.32 | 400,000 | 1,328,000 | 400,000 | |
| Jan 30 2018 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Option Exercise | A | 19.39 | 22,843 | 442,926 | 22,843 | |
| Jan 30 2018 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Grant | A | 0.00 | 8,566 | 0 | 93,817 | 85.3 K to 93.8 K (+10.05 %) |
| Dec 15 2017 | QURE | uniQure N.V. | Firuta Paul E | Chief Commercial Of ... | Grant | A | 0.00 | 56,115 | 0 | 56,115 | 0 to 56.1 K |